-
ISSCR Urges UK Agency to Increase Enforcement for the Marketing of Unproven Products
The ISSCR writes UK agency to urge for increased enforcement activities to prevent the marketing and commercialization of stem cell-related products.Full story -
ISSCR Comments on Need to Improve ClinicalTrials.gov Database to Prevent Abuse
The ISSCR issues a comment letter urging that more efforts must be made to prevent the ClinicalTrials.gov database from being abused by clinics marketing unproven stem cell interventions.Full story -
ISSCR Statement on COVID-19
We are looking forward to seeing all of you at the ISSCR annual meeting 23-27 June in Boston, US and to delivering an exceptional annual meeting. Even as the Society is immersed in preparations for ISSCR 2020, we remain acutely aware that our members may be personally and professionally affected by COVID-19, just as so many individuals and communities are across the world.Full story
Media Contact
